http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111044718-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-585 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-531 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54326 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-531 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-76 |
| filingDate | 2019-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111044718-B |
| titleOfInvention | Diluent for whole blood immune luminescence analysis and analysis method thereof |
| abstract | The invention discloses a diluent for whole blood immunofluorescence analysis, which comprises the following components in percentage by mass: 0.1-1% of PBS (PBS) 5-20 mmol/L, BSA0.1, 0.1-0.1% of PC-3000.01 and 0.01-0.5% of dispersing agent. The method comprises the steps of sequentially adding diluent for the immune luminescence analysis of the whole blood, calibrator and magnetic particle suspension coupled with PCT antibody into a reaction tube, oscillating and mixing uniformly, incubating at 37 ℃ for 10-30 min, separating, cleaning, continuously adding acridinium ester marker into the washed reaction container, incubating for 12min, separating, cleaning, and testing in a full-automatic luminometer to perform the immune luminescence analysis of the whole blood. The invention has the beneficial effects that: and adding a sample diluent, and adding a dispersing agent into the sample diluent, wherein the dispersing agent can enable the antigen and the antibody to fully react, the luminous value of the fluorescent material is greatly improved compared with that of the fluorescent material without the dispersing agent, and the CV change is small. |
| priorityDate | 2019-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 28.